Adrenocortical carcinoma staging: Difference between revisions
No edit summary |
|||
Line 11: | Line 11: | ||
{| {{table}} | {| {{table}} | ||
| | | TX | ||
| | | Primary tumor cannot be assessed. | ||
|- | |- | ||
| T0||No evidence of primary tumor. | | T0||No evidence of primary tumor. | ||
Line 20: | Line 20: | ||
| T2||Tumor >5 cm, no extra-adrenal invasion. | | T2||Tumor >5 cm, no extra-adrenal invasion. | ||
|- | |- | ||
| T3||Tumor of any size with local invasion, but not invading adjacent organs. | | T3||Tumor of any size with local invasion, but not invading adjacent organs. | ||
|- | |- | ||
| T4||Tumor of any size with invasion of adjacent organs. | | T4||Tumor of any size with invasion of adjacent organs. | ||
|- | |- | ||
|} | |} | ||
Line 29: | Line 29: | ||
{| {{table}} | {| {{table}} | ||
| | | NX | ||
| | | Regional lymph nodes cannot be assessed. | ||
|- | |- | ||
| N0||No regional lymph node metastasis. | | N0||No regional lymph node metastasis. | ||
Line 39: | Line 39: | ||
Staging according to [[metastasis]] (M): | Staging according to [[metastasis]] (M): | ||
{| {{table}} | {| {{table}} | ||
| | | M0 | ||
| | | No distant metastasis. | ||
|- | |- | ||
| M1||Distant metastasis. | | M1||Distant metastasis. | ||
Line 47: | Line 47: | ||
Staging according to [[TNM staging system]]: | Staging according to [[TNM staging system]]: | ||
{|{{table}} | {|{{table}} | ||
| | | Stage | ||
| | | T | ||
| | | N | ||
| | | M | ||
|- | |- | ||
| I||T1||N0||M0 | | I||T1||N0||M0 |
Revision as of 14:18, 27 August 2015
Adrenocortical carcinoma Microchapters |
Differentiating Adrenocortical carcinoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Study |
Adrenocortical carcinoma staging On the Web |
American Roentgen Ray Society Images of Adrenocortical carcinoma staging |
Risk calculators and risk factors for Adrenocortical carcinoma staging |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]
Overview
According to the TNM staging system, there are four stages of adrenocortical cancer based on the tumor size, lymph nodes, and distant metastasis. Each stage is assigned a number and letter that designates the number of lymph nodes involved and presence/absence of distant metastasis.
Staging of adrenocortical carcinoma
The AJCC has designated staging by TNM to define adrenocortical carcinoma
Staging according to tumor size (T):
TX | Primary tumor cannot be assessed. |
T0 | No evidence of primary tumor. |
T1 | Tumor ≤5 cm in greatest dimension, no extra-adrenal invasion. |
T2 | Tumor >5 cm, no extra-adrenal invasion. |
T3 | Tumor of any size with local invasion, but not invading adjacent organs. |
T4 | Tumor of any size with invasion of adjacent organs. |
Staging according to regional lymph nodes (N):
NX | Regional lymph nodes cannot be assessed. |
N0 | No regional lymph node metastasis. |
N1 | Metastases in regional lymph node(s). |
Staging according to metastasis (M):
M0 | No distant metastasis. |
M1 | Distant metastasis. |
Staging according to TNM staging system:
Stage | T | N | M |
I | T1 | N0 | M0 |
II | T2 | N0 | M0 |
III | T1 | N1 | M0 |
T2 | N1 | M0 | |
T3 | N0 | M0 | |
IV | T3 | N1 | M0 |
T4 | N0 | M0 | |
T4 | N1 | M0 | |
Any T | Any N | M1 |